Bharat Biotech has begun chikungunya vaccine Phase I trial
The Hyderabad-based Bharat Biotech has begun a Phase I human clinical trial of the indigenously developed chikungunya vaccine three months ago. The vaccine uses a killed virus. The Phase I…
Category: vaccine
Seventy-year journey of Zika virus
Zika is an arbovirus infection which occurs through the bite of several different species of Aedes mosquitoes, including the Aedes aegypti which is active during the day; it can also…
The big test for malaria vaccine RTS,S
Beginning next year, the World Health Organisation will begin pilot tests of the injectable malaria vaccine RTS,S (or Mosquirix) on 750,000 children aged 5-17 months in Ghana, Kenya and Malawi.…
Zika vaccine Phase I trial to begin next month in India
Bharat Biotech International Ltd in Hyderabad will start a Phase I clinical trial of Zika virus vaccine (MR 766) in two centres in India next month. The inactivated vaccine being…
Bharat Biotech’s Zika virus vaccine confers 100% protection in mice
The Hyderabad-based Bharat Biotech’s killed (inactivated) Zika virus vaccine using an African strain (MR 766) has shown 100% efficacy against mortality and disease in animal studies. A ‘killed virus vaccine’…
TB vaccine trial on adults begins in June in India
In June this year, the Pune-based Serum Institute of India Pvt Limited will begin a Phase II/III vaccine trial for tuberculosis using a novel, recombinant BCG (bacillus Calmette-Guérin) vaccine. The…
Can health spending of 2.5% of GDP only by 2025 help achieve the goals set by India’s National Health Policy?
The long awaited National Health Policy announced a few days ago proposes to raise public health expenditure as a percentage of GDP from the current 1.15% to 2.5% by 2025.…
WHO’s website for vaccine safety information gains traction
The extent to which rumours about the safety of vaccines can impact the number of children vaccinated was witnessed in Tamil Nadu during the measles-rubella vaccination drive last month. Only…
